↓ Skip to main content

Cost-effectiveness and cost-utility of hypertension and hyperlipidemia collaborative management between pharmacies and primary care in portugal alongside a trial compared with usual care (USFarmácia®)

Overview of attention for article published in Frontiers in Pharmacology, September 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness and cost-utility of hypertension and hyperlipidemia collaborative management between pharmacies and primary care in portugal alongside a trial compared with usual care (USFarmácia®)
Published in
Frontiers in Pharmacology, September 2022
DOI 10.3389/fphar.2022.903270
Pubmed ID
Authors

Suzete Costa, José Guerreiro, Inês Teixeira, Dennis K. Helling, João Pereira, Céu Mateus

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 12%
Researcher 2 8%
Student > Doctoral Student 2 8%
Unspecified 1 4%
Other 1 4%
Other 2 8%
Unknown 15 58%
Readers by discipline Count As %
Medicine and Dentistry 4 15%
Pharmacology, Toxicology and Pharmaceutical Science 2 8%
Nursing and Health Professions 2 8%
Unspecified 1 4%
Business, Management and Accounting 1 4%
Other 2 8%
Unknown 14 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 September 2022.
All research outputs
#20,699,786
of 23,299,593 outputs
Outputs from Frontiers in Pharmacology
#10,523
of 16,736 outputs
Outputs of similar age
#346,144
of 435,528 outputs
Outputs of similar age from Frontiers in Pharmacology
#821
of 1,462 outputs
Altmetric has tracked 23,299,593 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,736 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,528 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,462 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.